GleanMark

NeuroLambda Therapeutics, Inc. Trademark Portfolio

NeuroLambda Therapeutics, Inc. owns 2 live USPTO trademarks across 3 Nice classes. Earliest filing: 2024-12-31; most recent: 2024-12-31.

Portfolio Overview

Total Marks2
Live Marks2
Registered0
Pending2
Earliest Filing2024-12-31
Latest Filing2024-12-31

Top Classes

Class 042 (Software & IT), Class 001 (Chemicals), Class 005 (Pharmaceuticals)

Recently Filed Applications

Top Marks

Related